Results 141 to 150 of about 292,147 (192)

Multimodal biomechanical dataset from transtibial amputees and able-bodied adults across five locomotion tasks. [PDF]

Sci Data
Abarca VE, Chavez J, Eulogio L, Viviano C, Elias DA.   +4 more
europepmc   +1 more source

Parasitological survey of <i>Toxocara canis</i> and <i>Ancylostoma caninum</i> in Puno urban parks (3825 m): Evidence of larval development under Andean conditions. [PDF]

Open Vet J
Castillo DDR, Gutiérrez ÁC.
europepmc   +1 more source

Impact of Contrast Volume Used After Percutaneous Coronary Procedures in Patients at Risk for Contrast-Induced Nephropathy. [PDF]

Arq Bras Cardiol
Freitas RAP, Tanajura LFL, Sousa AGMR, Feres F, Costa JR.   +4 more
europepmc   +1 more source

Survival Rates of Pancreatic and Periampullary Adenocarcinoma Patients with Oligometastasis Surgically Managed at UP-PGH: A Ten-year Single-center Experience. [PDF]

Acta Med Philipp
Bacaro TMD, Berberabe AEB, Ang DG.
europepmc   +1 more source

<i>Fusarium</i> and <i>Alternaria</i> Toxins in Italian Heritage Common Wheat: Influence of Varieties and Alkylresorcinol Content. [PDF]

Foods
Bertuzzi T, Locatelli S, Lanzanova C, Cassol H, Siboni F, Battaglia R, Giorni P, Vaccino P.   +7 more
europepmc   +1 more source

Transhepatic Access for Mitral Valve Replacement: Transhepatic Transseptal Mitral Valve-in-Valve. [PDF]

JACC Case Rep
Marcondes Lemos LF, Alexandre de Alvim Siqueira D, Augusto Cardoso Pedra C, Cervone AC, Souza MO, Francisco Pinto IM, de Andrade Vilela A, Della Togna DJ, Isabel de Oliveira Ramos A, Feres F.   +9 more
europepmc   +1 more source

Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence. [PDF]

J Gastric Cancer
Kim YJ, Kim HD, Hyung J, Ryu MH.
europepmc   +1 more source

DANTE-CAIPI Accelerated Contrast-Enhanced 3D T1: Deep Learning-Based Image Quality Improvement for Vessel Wall MRI. [PDF]

AJNR Am J Neuroradiol
Kharaji M, Canton G, Guo Y, Mosi MH, Zhou Z, Balu N, Mossa-Basha M.   +6 more
europepmc   +1 more source

MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy.

Ophthalmologica
Zhou AW, Sahraravand RA, Baumann LM, Teagle GM, Brown J, Pieramici D, Holy SE, Borne MJ, Wong RW, Cunningham MA, Pearce WA, Rahman EZ, Chang M, Bhavsar AR, Brown DM, Alfaro DV, Fan KC, Cehofski LJ, Ip M, Sadda SR, Lesmes LA, Ehlers JP, Chaudhary V, Al-Khersan H, Wykoff CC.   +24 more
europepmc   +1 more source